CATHERINE J. MACKEY - 14 Dec 2022 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
Director
Signature
/s/ Stephen Hedberg, by Power of Attorney for Catherine J. Mackey, Ph.D.
Issuer symbol
CDMO
Transactions as of
14 Dec 2022
Transactions value $
$0
Form type
4
Filing time
16 Dec 2022, 19:01:21 UTC
Previous filing
16 Aug 2022
Next filing
07 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +4,632 +195% 7,011 14 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -4,632 -100% $0* 0 14 Dec 2022 Common Stock 4,632 Direct F1, F2
transaction CDMO Restricted Stock Units Award $0 +9,612 $0 9,612 14 Dec 2022 Common Stock 9,612 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022.
F3 Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
F4 The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date.